A-366

Epigenetic / Nootropic research

Epigenetic research tool with cognition implications

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Small molecule
Primary mechanism: G9a/GLP histone methyltransferase inhibition
Primary market use: Cognition research

Pharmacology

Molecular weight (Da): 447.5
Oral bioavailability: Unknown
Half-life: ~2–12 h small-molecule class estimate
Route tags: SubQ; Injectable; route-dependent
Evidence level: Preclinical
Clinical status: Research tool
Value-for-money score: 3 / 10

Reported protocol signal

No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Not a consumer-ready compound

Sources

https://pubchem.ncbi.nlm.nih.gov/